Mentions: pharmaceutical
Canada’s health care system is not providing full value for public money spent and needs to be urgently “rewired”    March 11, 2026

Mark Lowey
Corporate R&D dips slightly in 2019 with Bombardier dropping 60%, and cannabis firms investing heavily    February 3, 2021

Jessica Brown










Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.